SAN FRANCISCO -- Another COVID-19 vaccine -- AstraZeneca -- is poised to arrive in the U.S., bringing a fourth option for Americans. Each vaccine is administered slightly differently, some can result ...

SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.

A Canadian advisory committee says Canadians who got the AstraZeneca shot for their first vaccine dose should not get the second one. It says they should get the Pfizer or Moderna vaccine for their ...

TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season. Moderna says it will manufacture vaccine doses for the ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

WASHINGTON -- The top U.S. infectious disease expert said AstraZeneca's suspension of final testing of its COVID-19 vaccine candidate shows "one of the safety valves" built into the studies to spot ...

The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the U.N. agency's partners to ship millions of doses to countries as ...

Oct 13 (Reuters) - Moderna Inc (MRNA.O), opens new tab said on Tuesday Canada's health ministry will review its experimental COVID-19 vaccine in real time, becoming the third vaccine maker to be ...

Health Canada says it is expediting the review of the COVID-19 vaccine from AstraZeneca (NASDAQ:AZN), hours after the adenovirus-based jab co-developed with the University of Oxford received the ...

Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...

AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the ...